Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in …
NL Albert, M Weller, B Suchorska, N Galldiks… - Neuro …, 2016 - academic.oup.com
This guideline provides recommendations for the use of PET imaging in gliomas. The review
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
examines established clinical benefit in glioma patients of PET using glucose (18F-FDG) …
Metabolic positron emission tomography imaging in cancer detection and therapy response
Positron emission tomography (PET) is a noninvasive imaging technique that provides a
functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18 …
functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18 …
Image-derived input function for brain PET studies: many challenges and few opportunities
P Zanotti-Fregonara, K Chen, JS Liow… - Journal of Cerebral …, 2011 - journals.sagepub.com
Quantitative positron emission tomography (PET) brain studies often require that the input
function be measured, typically via arterial cannulation. Image-derived input function (IDIF) …
function be measured, typically via arterial cannulation. Image-derived input function (IDIF) …
[HTML][HTML] Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy–detecting illusive disease, defining response
Glioblastoma, the most common malignant primary brain tumor in adults is a devastating
diagnosis with an average survival of 14–16 months using the current standard of care …
diagnosis with an average survival of 14–16 months using the current standard of care …
[HTML][HTML] Monitoring and modelling the dynamics of the cellular glycolysis pathway: A review and future perspectives
Background The dynamics of the cellular glycolysis pathway underpin cellular function and
dysfunction, and therefore ultimately health, disease, diagnostic and therapeutic strategies …
dysfunction, and therefore ultimately health, disease, diagnostic and therapeutic strategies …
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery
Purpose We assessed the performance of 6-[18 F]-fluoro-l-3, 4-dihydroxyphenylalanine (F-
DOPA) PET for differentiating radionecrosis (RN) from tumour progression (PD) in a …
DOPA) PET for differentiating radionecrosis (RN) from tumour progression (PD) in a …
18F-FDOPA PET for the noninvasive prediction of glioma molecular parameters: a radiomics study
The assessment of gliomas by 18F-FDOPA PET imaging as an adjunct to MRI showed high
performance by combining static and dynamic features to noninvasively predict the isocitrate …
performance by combining static and dynamic features to noninvasively predict the isocitrate …
Intra-individual comparison of 18F-FET and 18F-DOPA in PET imaging of recurrent brain tumors
C Kratochwil, SE Combs, K Leotta… - Neuro …, 2014 - academic.oup.com
Abstract Background Both 18F-fluorodihydroxyphenylalanine (18F-DOPA) and 18F-
fluoroethyltyrosine (18F-FET) have already been used successfully for imaging of brain …
fluoroethyltyrosine (18F-FET) have already been used successfully for imaging of brain …
Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors
C Juhász, S Dwivedi, DO Kamson… - Molecular …, 2014 - journals.sagepub.com
Positron emission tomography (PET) is an imaging technology that can detect and
characterize tumors based on their molecular and biochemical properties, such as altered …
characterize tumors based on their molecular and biochemical properties, such as altered …
Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
J Schwarzenberg, J Czernin, TF Cloughesy… - Clinical Cancer …, 2014 - AACR
Purpose: This study compares the value of 3, 4-dihydroxy-6-[18F]-fluoro-l-phenylalanine
(18F-FDOPA) positron emission tomography (PET) and MRI in assessing outcome during …
(18F-FDOPA) positron emission tomography (PET) and MRI in assessing outcome during …